Crinetics Pharmaceuticals, Inc.

CRNX

NASDAQ

Healthcare

Biotechnology

San Diego, CA, US437 employeescrinetics.com

$37.10

+0.54(1.5%)

52W $25.56 – $56.43

AI-generated

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-rela...

Revenue breakdown: License And Service (44.8%), Product (33.2%), License (22%).

$3.9BMkt Cap

$6MRev TTM

-$518MNI TTM

-7.0xP/E TTM

Latest Earnings

10-K

FY FY2025Feb 25, 2026

10-K for FY2025 was filed on 2026-02-26. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Management Change

Mar 22, 2026

Departure of Directors or Certain Officers; Election of Directors, Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 17,

View filing →

Auditor Change

Mar 2, 2026

Changes in Registrant's Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On February 27, 2026, the Audit Committee (the "Au

View filing →

Financial Results

Feb 25, 2026

Results of Operations and Financial Condition. On February 26, 2026 , Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) issued a press release repo

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

License And Service44.8%($15M)

Product33.2%($11M)

License22%($7M)

Analyst View

Peer Companies

Company	Price	Change	Market Cap	P/E
KYMRKymera Therapeutics, Inc.	$85.33	+0.47%	$7.0B	-20.9
PRAXPraxis Precision Medicine...	$310.78	-2.66%	$6.6B	-21.8
IMVTImmunovant, Inc.	$24.67	-1.70%	$5.0B	-9.5
AKROAKRO	$54.65	+0.00%	$4.5B	—
XENEXenon Pharmaceuticals Inc...	$56.70	+0.02%	$4.5B	-12.5
VKTXViking Therapeutics, Inc.	$34.87	+5.79%	$4.0B	-10.3
NAMSNewAmsterdam Pharma Compa...	$33.02	+0.64%	$3.8B	-16.8
ACADACADIA Pharmaceuticals In...	$22.18	-0.65%	$3.8B	9.1

Company Profile

CIK0001658247

ISINUS22663K1079

CUSIP22663K107

Phone858 450 6464

AddressBuilding No. 2, San Diego, CA, 92121, US

SEC EDGAR